Who owns Climb Bio, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of CLYM from SEC Form 13F filings across 107 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 107 institutions disclosed 56.3M shares of Climb Bio, Inc. worth $734.2M — about 74% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
107
13F holders
$734.2M
value, 2026 filers
74%
of shares outstanding (56.3M sh)
50
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CLYM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 11.3M | $147.4M | 1.3% | 14.8% | 0.0% |
| 2 | FMR LLC | 6.8M | $88.5M | 0.0% | 8.9% | +106049.2% |
| 3 | UBS Group AG | 3.4M | $44.4M | 0.0% | 4.5% | +3861.7% |
| 4 | BRAIDWELL LP | 2.8M | $36.5M | 1.3% | 3.7% | +82.9% |
| 5 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 2.5M | $32.7M | 0.0% | 3.3% | new |
| 6 | BlackRock, Inc. | 2.4M | $30.7M | 0.0% | 3.1% | +486.3% |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.1M | $27.7M | 0.0% | 2.8% | +11.0% |
| 8 | Cormorant Asset Management, LPNEW | 2.1M | $27.5M | 1.4% | 2.8% | new |
| 9 | FRONTIER CAPITAL MANAGEMENT CO LLCNEW | 1.9M | $25.3M | 0.2% | 2.5% | new |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $22.2M | 0.0% | 2.2% | +44.1% |
| 11 | Woodline Partners LPNEW | 1.6M | $20.6M | 0.1% | 2.1% | new |
| 12 | CITADEL ADVISORS LLC | 1.3M | $16.9M | 0.0% | 1.7% | +275.5% |
| 13 | Redmile Group, LLCNEW | 1.2M | $16.0M | 1.1% | 1.6% | new |
| 14 | GREAT POINT PARTNERS LLC | 1.0M | $13.0M | 2.5% | 1.3% | -25.0% |
| 15 | Affinity Asset Advisors, LLC | 972,000 | $12.7M | 0.6% | 1.3% | +38.9% |
| 16 | MILLENNIUM MANAGEMENT LLC | 908,198 | $11.8M | 0.0% | 1.2% | -28.8% |
| 17 | ADAR1 Capital Management, LLC | 822,649 | $10.7M | 0.5% | 1.1% | +37.6% |
| 18 | Driehaus Capital Management LLC | 790,000 | $10.3M | 0.1% | 1% | +31.5% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 782,199 | $10.2M | 0.0% | 1% | +149.9% |
| 20 | STEMPOINT CAPITAL LPNEW | 742,745 | $9.7M | 1.7% | 1% | new |
| 21 | STATE STREET CORP | 686,772 | $9.0M | 0.0% | 0.9% | +420.3% |
| 22 | AMERIPRISE FINANCIAL INCNEW | 657,971 | $8.6M | 0.0% | 0.9% | new |
| 23 | Parkman Healthcare Partners LLCNEW | 563,484 | $7.3M | 0.8% | 0.7% | new |
| 24 | SUPERSTRING CAPITAL MANAGEMENT LP | 521,082 | $6.8M | 4.3% | 0.7% | +161.6% |
| 25 | SPHERA FUNDS MANAGEMENT LTD. | 483,747 | $6.3M | 0.8% | 0.6% | +15.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.